Mass spectrometry for the quantification of bioactive peptides in biological fluids
- 7 December 2006
- journal article
- review article
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 26 (3) , 389-402
Abstract
The study of pharmacologically active peptides is central to the understanding of disease and development of novel therapies. It would be advantageous to monitor the fate of bioactive peptides in biological fluids and tissues following their in vivo administration (exogenous administration) or the modulation of endogenous factors (e.g., peptide hormones) affected by the administration of a pharmacological agent. Measurement of administered compounds (small molecules) in plasma is a mature field. However, measurement of pharmacologically active peptides presents particular problems for quantitative mass spectrometry, including challenges from selectivity and sensitivity perspectives. Current approaches towards peptide quantification in biological fluids include immunoassays and mass spectrometric techniques. Immunoassays, although sensitive, lack the necessary selectivity for distinction between peptide and metabolites. Modified molecules induced by metabolic transformations (e.g., N‐ or C‐terminal truncation of the peptide) might not be differentiated by the antibody used in the assay, leading to cross‐reactivity. However, although it is generally accepted that mass spectrometry is an ideal technique for the quantification of trace levels of analytes in biological fluids, immunological techniques are still characterized by better limits of peptide detection. In this review article, novel mass spectrometric approaches and strategies on peptide quantification will be described. The current capabilities and prospects for advances in this critical area of research will be examined. © 2006 Wiley Periodicals, Inc., Mass Spec RevKeywords
This publication has 61 references indexed in Scilit:
- Design, Synthesis, and Molecular Modeling of a Novel Amide-Linked Cyclic GnRH Analogue Cyclo(4−9)[Lys4,d-Trp6,Glu9]GnRH: Stimulation of Gonadotropin Gene ExpressionJournal of Medicinal Chemistry, 2005
- Quantification of acetylation at proximal lysine residues using isotopic labeling and tandem mass spectrometryMethods, 2005
- High Throughput Proteome Screening for Biomarker DetectionMolecular & Cellular Proteomics, 2005
- Qualitative and quantitative analysis of low molecular weight compounds by ultraviolet matrix‐assisted laser desorption/ionization mass spectrometry using ionic liquid matricesRapid Communications in Mass Spectrometry, 2003
- Clinical biomarkers in drug discovery and developmentNature Reviews Drug Discovery, 2003
- Mass spectrometry-based proteomicsNature, 2003
- Growth hormone abuse in the horse: preliminary assessment of a mass spectrometric procedure for IGF‐1 identification and quantitationRapid Communications in Mass Spectrometry, 2001
- Determination of brain and plasma drug concentrations by liquid chromatography/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2000
- Minireview quantitative analytical mass spectrometry of endogenous neuropeptides in human pituitariesLife Sciences, 1992
- Mass spectrometric quantification of endogenous β-endorphinJournal of Mass Spectrometry, 1991